Effect of Berry Extracts and Bioactive Compounds on Fulvestrant (ICI 182,780) Sensitive and Resistant Cell Lines
Fulvestrant (ICI 182,780; ICI) is approved for the treatment of advanced metastatic breast cancer that is unresponsive to other endocrine therapies. Berries are frequently consumed for their antioxidant, anti-inflammatory, and anticancer potential. In this study, we tested the efficacy of two berry...
Main Authors: | Denzel R. Woode, Harini S. Aiyer, Nicole Sie, Alan L. Zwart, Liya Li, Navindra P. Seeram, Robert Clarke |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2012/147828 |
Similar Items
-
Induction of miR-765 by antiestrogen ICI 182,780 in prostate cancer cells.
Published: (2011) -
The effects of genistein and ICI182,780 alone or combined on the growth of lung tumor and normal cells
by: Pei-Hua, et al.
Published: (2008) -
Gonadal steroids differentially modulate neurotoxicity of HIV and cocaine: testosterone and ICI 182,780 sensitive mechanism
by: Mactutus Charles F, et al.
Published: (2005-06-01) -
ICI 182,780 has agonistic effects and synergizes with estradiol-17 beta in fish liver, but not in testis
by: Power Deborah M, et al.
Published: (2006-12-01) -
Tamoxifen and ICI 182,780 activate GPER-1 in orphanin FQ neurons to facilitate sexual receptivity in female rats
by: Long, Nathan P.
Published: (2016)